SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001711279-24-000014
Filing Date
2024-04-04
Accepted
2024-04-04 16:09:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A noticeofinternetavailabili.htm DEFA14A 13133
2 krystalbiotechinc_vxnaxp02.jpg GRAPHIC 487664
3 krystalbiotechinc_vxnaxp02a.jpg GRAPHIC 331254
  Complete submission text file 0001711279-24-000014.txt   1141642
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38210 | Film No.: 24823231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)